Timber Pharmaceuticals, Inc.
TMBR
|
$0.3426
-2.69%
3K
|
Health Technology
(0.0% 1d) (0.0% 1m) (-76.4% 1y) (0.0% 2d) (0.0% 3d) (1.4% 7d) (-100.0% volume)
Earnings Calendar:
Market Cap: $ 1,176,055
http://www.timberpharma.com/
Sec Filling | Patents | 3 employees
(US) Timber Pharmaceuticals, Inc. operates as a biopharmaceutical company, which focuses on the development and commercialization of treatments for orphan dermatologic diseases. Its initial focus on developing non-systemic treatments for rare dermatologic diseases, including congenital ichthyosis, tuberous sclerosis complex and localized scleroderma. The company is headquartered in Woodcliff Lake, NJ.
sclerosis msa treatment
add to watch list Paper trade email alert is off
Press-releases
Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE American
Published: 2023-11-28 (Crawled : 22:00) - globenewswire.com
TMBR | $0.3426 -2.69% 3K
|
Health Technology
| Email alert
Add to watchlist
business approval pharmaceuticals communication
Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance
Published: 2023-09-18 (Crawled : 20:00) - globenewswire.com
TMBR | $0.3426 -2.69% 3K
|
Health Technology
|
| O: 0.0%
H: 2.67%
C: 0.0%
pharmaceuticals
Timber Pharmaceuticals to be Acquired by LEO Pharma
Published: 2023-08-21 (Crawled : 12:00) - globenewswire.com
TMBR | $0.3426 -2.69% 3K
|
Health Technology
|
| O: 104.23%
H: 10.34%
C: 3.1%
leo pharma pharmaceuticals acquired
Timber Pharmaceuticals Discloses Communication From NYSE American
Published: 2023-07-03 (Crawled : 20:00) - globenewswire.com
TMBR | $0.3426 -2.69% 3K
|
Health Technology
| Email alert
Add to watchlist
pharmaceuticals communication
Timber Pharmaceuticals to Present Interim Analyses From Phase 3 ASCEND Study of TMB-001 in Congenital Ichthyosis
Published: 2023-06-20 (Crawled : 12:00) - globenewswire.com
TMBR | $0.3426 -2.69% 3K
|
Health Technology
|
| O: 4.0%
H: 0.0%
C: -0.96%
tmb-001 pharmaceuticals study
Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001
Published: 2023-06-05 (Crawled : 12:00) - globenewswire.com
TMBR | $0.3426 -2.69% 3K
|
Health Technology
|
| O: 33.56%
H: 36.99%
C: -5.53%
tmb-001 fda pharmaceuticals grant
Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2023 Financial Results
Published: 2023-05-15 (Crawled : 20:00) - globenewswire.com
TMBR | $0.3426 -2.69% 3K
|
Health Technology
|
| O: -13.66%
H: 9.35%
C: 5.76%
business update pharmaceuticals financial results
Timber Pharmaceuticals Announces Publication of Sub-Analysis of Phase 2b CONTROL study in Clinical and Experimental Dermatology
Published: 2023-03-20 (Crawled : 13:20) - biospace.com/
TMBR | $0.3426 -2.69% 3K
|
Health Technology
|
| O: 3.19%
H: 1.16%
C: -9.27%
control publication pharmaceuticals study
Timber Pharmaceuticals Receives European Orphan Drug Designation for TMB-001 in X-Linked Recessive Ichthyosis
Published: 2023-02-24 (Crawled : 13:20) - globenewswire.com
TMBR | $0.3426 -2.69% 3K
|
Health Technology
|
| O: 19.69%
H: 41.99%
C: 14.72%
tmb-001 pharmaceuticals designation drug
Timber Pharmaceuticals to Host Investor Business Briefing: Milestone Achievements and Forward Outlook
Published: 2022-12-14 (Crawled : 14:00) - globenewswire.com
TMBR | $0.3426 -2.69% 3K
|
Health Technology
|
| O: -0.84%
H: 20.74%
C: 17.04%
pharmaceuticals milestone
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
| 0001437749-23-024472 | 4 | 2023-08-22 | 2023-08-20 | Buy | A | 70385 | 70785 |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M
|
n/a
|
23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M
|
Finance
|
22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K
|
Health Technology
|
22:30
BCDA P 2750 | $0.377 -1.4% 97K
|
Health Technology
|
22:00
RMCF | $3.67 3.38% 3.27% 11K
|
Consumer Non-Durables
|
20:10